Business

Conference attendance at ShareSoc Leeds

Tristel plc announced that its Chief Financial Officer will present an overview of the company and its strategy at the ShareSoc Growth Company investor event on April 14, 2026, in Leeds. No new financial information will be disclosed during this presentation, and a PDF of the slides will be made available on the company's investor relations website. Disclaimer*

articleTristel PlcMarch 18, 20263/news/conference-attendance-at-sharesoc-leeds
Conference attendance at ShareSoc Leeds

About this update from Tristel Plc

  Tristel plc ("Tristel" or the "Company")   Conference attendance at ShareSoc Leeds                 Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting at the ShareSoc Growth Company investor event on 14 April 2026, which will be held at Clayton Hotel, City Walk, Sweet Street, Leeds, LS11 9AT.   Anna Wasyl, CFO of Tristel plc, will present an overview of the Company and strategy. No new information will be disclosed at the event and a PDF of the presentation will be made available on the Company's website at  https://investors.tristel.com/investor-hub/.   For further information and to register for ShareSoc, please visit the event website at https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-person-event-leeds-2/.   For further information please contact:        Tristel plc Via Walbrook PR Matt Sassone, Chief Executive Officer www.investors.tristel.com Anna Wasyl, Chief Financial Officer Walbrook PR Ltd Tel: 020 7933 8780 or [email protected] Paul McManus / Lianne Applegarth / Anna Dunphy   Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 Cavendish Capital Markets Ltd Tel: 020 7220 0500 Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance) Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)   About Tristel plc   Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.   Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.   The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).   For more information about Tristel's product range please visit: https://tristel.com    

View stock analysis, news, and events for Tristel Plc